Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial-Reference-Cited by-同舟云学术

Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial

Published:2021-07 Issue:7 Volume:16 Page:1118-1126
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Han Dae Hee,Duan Fenghai,Wu Yanning,Goo Jin Mo,Kim Hyae Young,Patz Edward F.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference12 articles.

1. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

2. National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design;Aberle;Radiology,2011

3. Lung CT Screening Reporting & Data System (Lung-RADS™). American College of Radiology. https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADS_AssessmentCategories.pdf. Accessed June 3, 2019.

4. Are lung imaging reporting and data system categories clear to radiologists? A survey of the Korean Society of Thoracic Radiology Members on Ten Difficult-to-classify scenarios;Han;Korean J Radiol,2017

5. Baseline characteristics of participants in the randomized National Lung Screening Trial;Aberle;J Natl Cancer Inst,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions;Journal of Thoracic Oncology;2023-04

2. Response to Letter to the Editor About Clinical Significance of Lung-RADS Category 3 Lesions;Journal of Thoracic Oncology;2023-04

3. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality;Cochrane Database of Systematic Reviews;2022-08-03

4. Do Cancer Screening Researchers Have a Continuing Ethical Obligation to Their Study Subjects?;Journal of Thoracic Oncology;2021-07